OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
September 02, 2010
In the Spotlight
Editors' picks of pharmaceutical science and technology innovations.
Weighing the pros and cons of REMS for bringing risky products to market.
The executive vice-president of sciences discusses industry trends and challenges.
The authors present three approaches that a contract development and manufacturing organization can consider when designing development and process-optimization studies that will provide useful data for scaling up a project.
Industry efforts toward global healthcare surpass average expectations.
A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.
Pending legislation may give FTC the authority to regulate all Hatch-Waxman settlements.
Pharmaceutical Technology gains insight into approaches for producing aromatic amines.
From weekend deliveries to nonsterile gloves, a single exception can make a product fall flat.
Software and online monitoring are helping the pharmaceutical industry improve its corrective and preventive action programs. This article contains bonus online material.
To properly inspect based on measurement, a reference standard is crucial for comparison.
PharmTech talked to anticounterfeiting experts to discuss terrorism as a source of counterfeit products.
Industry participation is crucial as USP embarks on far-reaching monograph modernization initiative. This is an online-exclusive article.
From The Editor
New data provide insight into pharma-industry professionals' daily lives.
In the final article of a three-part series, the authors discuss how to present a design space and evaluate its graphical representation.
Changing demands in drug development lead to new service combinations and models.
September 01, 2010